中华器官移植杂志
中華器官移植雜誌
중화기관이식잡지
CHINESE JOURNAL OF ORGAN TRANSPLANTATION
2014年
4期
211-215
,共5页
刘绪忠%刘超%汪俊%韩志坚%陶俊%鲁佩%殷长军%谭若芸%顾民
劉緒忠%劉超%汪俊%韓誌堅%陶俊%魯珮%慇長軍%譚若蕓%顧民
류서충%류초%왕준%한지견%도준%로패%은장군%담약예%고민
肾移植%西罗莫司%动脉粥样硬化%晚期糖基化终末产物
腎移植%西囉莫司%動脈粥樣硬化%晚期糖基化終末產物
신이식%서라막사%동맥죽양경화%만기당기화종말산물
Kidney transplantion%Sirolimus%Artherosclerosis%AGE
目的 探讨肾移植术后西罗莫司抑制晚期糖基化终末产物(AGE)诱导的动脉粥样硬化(AS)形成的作用及其机制.方法 纳入5例肾移植后确诊AS形成的受者,受者在发生AS前接受过移植肾穿刺活检,确诊AS后则使用西罗莫司抗排斥反应治疗1年以上,观察使用西罗莫司前后移植肾血管组织的结构变化.体外分离和培养SD大鼠主动脉平滑肌细胞(VSMC),并以免疫荧光染色法进行鉴定;以第5代VSMC为体外实验对象,取第5代VSMC,将细胞分为西罗莫司组(经西罗莫司培养)、AGE组(经AGE培养)、实验组(经西罗莫司和AGE共培养)及对照组(经牛血清蛋白培养),收集各组VSMC,采用蛋白质印迹法检测VSMC上α平滑肌肌动蛋白(α-SMA)、骨桥蛋白(OPN)和增殖细胞核抗原(PCNA)的表达.结果 肾移植后AS形成受者的血管中膜明显增厚,而使用西罗莫司处理(13.0±1.8)个月后,中膜厚度则显著降低.体外实验表明,正常SD大鼠第2、5代VSMC中α-SMA均高度表达;经AGE作用后可诱导VSMC中α-SMA表达量明显减少(P<0.05);而OPN和PCNA的表达明显升高(P<0.05).此外,与AGE组相比,实验组VSMC中PCNA和OPN的表达明显下降,而α-SMA表达量明显上升,差异均有统计学意义(P<0.05).结论 西罗莫司可能通过抑制AGE诱导的血管平滑肌细胞增殖及其表型的转分化进而抑制AGE引起的肾移植后AS的进展.
目的 探討腎移植術後西囉莫司抑製晚期糖基化終末產物(AGE)誘導的動脈粥樣硬化(AS)形成的作用及其機製.方法 納入5例腎移植後確診AS形成的受者,受者在髮生AS前接受過移植腎穿刺活檢,確診AS後則使用西囉莫司抗排斥反應治療1年以上,觀察使用西囉莫司前後移植腎血管組織的結構變化.體外分離和培養SD大鼠主動脈平滑肌細胞(VSMC),併以免疫熒光染色法進行鑒定;以第5代VSMC為體外實驗對象,取第5代VSMC,將細胞分為西囉莫司組(經西囉莫司培養)、AGE組(經AGE培養)、實驗組(經西囉莫司和AGE共培養)及對照組(經牛血清蛋白培養),收集各組VSMC,採用蛋白質印跡法檢測VSMC上α平滑肌肌動蛋白(α-SMA)、骨橋蛋白(OPN)和增殖細胞覈抗原(PCNA)的錶達.結果 腎移植後AS形成受者的血管中膜明顯增厚,而使用西囉莫司處理(13.0±1.8)箇月後,中膜厚度則顯著降低.體外實驗錶明,正常SD大鼠第2、5代VSMC中α-SMA均高度錶達;經AGE作用後可誘導VSMC中α-SMA錶達量明顯減少(P<0.05);而OPN和PCNA的錶達明顯升高(P<0.05).此外,與AGE組相比,實驗組VSMC中PCNA和OPN的錶達明顯下降,而α-SMA錶達量明顯上升,差異均有統計學意義(P<0.05).結論 西囉莫司可能通過抑製AGE誘導的血管平滑肌細胞增殖及其錶型的轉分化進而抑製AGE引起的腎移植後AS的進展.
목적 탐토신이식술후서라막사억제만기당기화종말산물(AGE)유도적동맥죽양경화(AS)형성적작용급기궤제.방법 납입5례신이식후학진AS형성적수자,수자재발생AS전접수과이식신천자활검,학진AS후칙사용서라막사항배척반응치료1년이상,관찰사용서라막사전후이식신혈관조직적결구변화.체외분리화배양SD대서주동맥평활기세포(VSMC),병이면역형광염색법진행감정;이제5대VSMC위체외실험대상,취제5대VSMC,장세포분위서라막사조(경서라막사배양)、AGE조(경AGE배양)、실험조(경서라막사화AGE공배양)급대조조(경우혈청단백배양),수집각조VSMC,채용단백질인적법검측VSMC상α평활기기동단백(α-SMA)、골교단백(OPN)화증식세포핵항원(PCNA)적표체.결과 신이식후AS형성수자적혈관중막명현증후,이사용서라막사처리(13.0±1.8)개월후,중막후도칙현저강저.체외실험표명,정상SD대서제2、5대VSMC중α-SMA균고도표체;경AGE작용후가유도VSMC중α-SMA표체량명현감소(P<0.05);이OPN화PCNA적표체명현승고(P<0.05).차외,여AGE조상비,실험조VSMC중PCNA화OPN적표체명현하강,이α-SMA표체량명현상승,차이균유통계학의의(P<0.05).결론 서라막사가능통과억제AGE유도적혈관평활기세포증식급기표형적전분화진이억제AGE인기적신이식후AS적진전.
Objective +o investigate the inhibitory effect of sirolimus on formation of atherosclerosis (AS) induced by advanced glycation end products (AGE) in kidney transplantation recipients and mechanism.Method Five cases of definite diagnosis of AS were included.Structural changes of renal transplant vascular tissues were observed before and after the application of sirolimus for at least over 1 year once the definite diagnosis of AS was made by transplant kidney aspiration biopsy.SD rat aortic smooth muscle cells (VSMC) were isolated and cultured in vitro and identified by immunofluorescence staining.Sirolimus group (sirolimus culture),AGE group (AGE culture),experimental group (sirolimus and AGE co-culture) and control group (bovine serum albumin culture) were established.VSMCs of the 5th generation from each group were collected and the expression levels of α-smooth muscle actin (α-SMA),osteopontin (OPN) and proliferating cell nuclear antigen (PCNA) were detected by Western blotting.Result Significant thickness was found in the media layer of vessels in allograft kidney from recipients with AS comparing with significant attenuation after the administration of sirolimus for 13.0 + 1.8 months.+he in vitro experiments showed that α-SMA was overexpressed in both 2 nd and 5 th generation VSMCs of normal SD rats; in contrast,low expression of α-SMA and high expression of OPN and PCNA were detected after the exposure of AGE (P< 0.05).Moreover,as compared with AGE group,PCNA and OPN were significantly decreased,and α-SMA was significantly increased in experimental group (P<0.05).Conclusion Sirolimus can inhibit the progression of post-transplant AS induced by AGE possibly through suppressing the proliferation of VSMCs and transdifferentiation of their phenotypes.